Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 1, 2007, Pages 43.e1-43.e6

  Struwe, Ellen ^a   Berzl, Gabriele M ^a   Schild, Ralf L ^a   Beckmann, Matthias W ^a   Dörr, Helmuth G ^a   Rascher, Wolfgang ^a   Dötsch, Jörg ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

11 hydroxysteroid dehydrogenase; birthweight; fetal programming; intrauterine growth restriction; placenta

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MALE; NEWBORN; PLACENTA; PLACENTA WEIGHT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 34347216676     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.02.012     Document Type: Article

References (29)

1. Barker D.J. The fetal origins of hypertension. J Hypertens Suppl 14 (1996) S117-S120
2. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., and Edwards C.R. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341 (1993) 339-341
3. Seckl J.R., Benediktsson R., Lindsay R.S., and Brown R.W. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension. J Steroid Biochem Mol Biol 55 (1995) 447-455
4. Stewart P.M., and Krozowski Z.S. 11 Beta-hydroxysteroid dehydrogenase. Vitam Horm 57 (1999) 249-324
5. Sun K., Yang K., and Challis J.R. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J Clin Endocrinol Metab 82 (1997) 300-305
6. Johnstone J.F., Bocking A.D., Unlugedik E., and Challis J.R. The effects of chorioamnionitis and betamethasone on 11beta hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor in preterm human placenta. J Soc Gynecol Investig 12 (2005) 238-245
7. Bujalska I., Shimojo M., Howie A., and Stewart P.M. Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 62 (1997) 77-82
8. Krozowski Z., Maguire J.A., Stein-Oakley A.N., Dowling J., Smith R.E., and Andrews R.K. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80 (1995) 2203-2209
9. Benediktsson R., Calder A.A., Edwards C.R., and Seckl J.R. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) 46 (1997) 161-166
10. Schoof E., Girstl M., Frobenius W., et al. Course of placental 11 beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation. Eur J Endocrinol 145 (2001) 187-192
11. Shams M., Kilby M.D., Somerset D.A., et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 13 (1998) 799-804
12. McTernan C.L., Draper N., Nicholson H., et al. Reduced placental 11 beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 86 (2001) 4979-4983
13. Challis J.R., Sloboda D., Matthews S.G., et al. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol 185 (2001) 135-144
14. Reinisch J.M., Simon N.G., Karow W.G., and Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202 (1978) 436-438
15. Ward R.M. Pharmacologic enhancement of fetal lung maturation. Clin Perinatol 21 (1994) 523-542
16. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151 Suppl 3 (2004) U49-U62
17. Alfaidy N., Xiong Z.G., Myatt L., Lye S.J., MacDonald J.F., and Challis J.R. Prostaglandin F2 alpha potentiates cortisol production by stimulating 11 beta-hydroxysteroid dehydrogenase 1: a novel feedback loop that may contribute to human labor. J Clin Endocrinol Metab 86 (2001) 5585-5592
18. Giannopoulos G., Jackson K., and Tulchinsky D. Glucocorticoid metabolism in human placenta, decidua, myometrium and fetal membranes. J Steroid Biochem 17 (1982) 371-374
19. Voigt M., Schneider K.T., and Jahrig K. [Analysis of a 1992 birth sample in Germany. 1: new percentile values of the body weight of newborn infants]. Geburtshilfe Frauenheilkd 56 (1996) 550-558
20. Schoof E., Girstl M., Frobenius W., et al. Decreased gene expression of 11 beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. J Clin Endocrinol Metab 86 (2001) 1313-1317
21. Tanswell A.K., Worthington D., and Smith B.T. Human amniotic membrane corticosteroid 11-oxidoreductase activity. J Clin Endocrinol Metab 45 (1977) 721-725
22. Murphy V.E., and Clifton V.L. Alterations in human placental 11 beta-hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta 24 (2003) 739-744
23. Li W., Gao L., Wang Y., Duan T., Myatt L., and Sun K. Enhancement of cortisol-induced 11 beta-hydroxysteroid dehydrogenase type 1 expression by interleukin 1 beta in cultured human chorionic trophoblast cells. Endocrinology 147 (2006) 2490-2495
24. Sagawa N., Yura S., Itoh H., et al. Role of leptin in pregnancy-a review. Placenta 23 Suppl A (2002) S80-S86
25. Barker D.J. Intrauterine programming of adult disease. Mol Med Today 1 (1995) 418-423
26. Sun K., He P., and Yang K. Intracrine induction of 11 beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast. Biol Reprod 67 (2002) 1450-1455
27. Yang K., Shearman K., Asano H., and Richardson B.S. Effects of hypoxemia on 11 beta-hydroxysteroid dehydrogenase types 1 and 2 gene expression in preterm fetal sheep. J Soc Gynecol Investig 4 (1997) 124-129
28. Stewart P.M., Rogerson F.M., and Mason J.I. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 80 (1995) 885-890
29. Rogerson F.M., Kayes K.M., and White P.C. Variation in placental type 2 11 beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol Cell Endocrinol 128 (1997) 103-109